SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Innerdyne -- Why are they still losing money?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mark collins who wrote (62)10/31/2000 6:33:47 PM
From: Charles W. Breaux, Jr.  Read Replies (2) of 68
 
To all:

For what it's worth, InnerDyne reported 3rd quarter results today:

quicken.com

SUNNYVALE, Calif.--(BW, news, msgs HealthWire)--Oct. 31, 2000--InnerDyne, Inc. (NASDAQ NM: IDYN) today reported financial results for the three and nine months ended September 30, 2000. Third quarter 2000 net income increased 231% to $1.19 million, or $0.05 per diluted share, compared with net income of $359 thousand, or $0.02 per share in 1999. Net income before tax was $1.2 million, an increase of 238% compared with net income before tax of $363 thousand in the third quarter of 1999. Third quarter 2000 total revenues increased 21% to $6.41 million, compared with $5.31 million in 1999, while product revenues rose 23% to $6.39 million. Gross margins in the third quarter 2000 exceeded 74%.

EPS up 150% relative to 3rd-quarter last year. I still think we're getting somewhat screwed in the takeover, getting only $7.50 TYC equivalent per IDYN share.

JMHO.

Chuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext